Chair Hilda L. Solis’ Statement on FDA’s Full Approval of the Pfizer Vaccine

2021-08-23T10:34:49-07:00August 23rd, 2021|COVID-19, In the news, Press Release|

LOS ANGELES - Chair Hilda L. Solis released the following statement in response to the FDA's full approval of the Pfizer vaccine: “This morning, I was incredibly excited to see that after a rigorous and thorough review, the FDA granted full approval to the Pfizer vaccine for those age 16 and above. Although millions of people [...]

Chair Hilda L. Solis’ Statement on the FDA’s Authorization and CDC’s Recommendation for an Additional COVID-19 Vaccine Dose for Immunocompromised Individuals

2021-08-13T16:32:02-07:00August 13th, 2021|COVID-19, In the news, Press Release|

LOS ANGELES - Chair Hilda L. Solis released the following statement after the U.S. Food and Drug Administration (FDA) announced its authorization and the Centers for Disease Control and Prevention (CDC) announced its recommendation of an additional COVID-19 vaccine dose for immunocompromised individuals: “Yesterday, the FDA granted authorization and today, the CDC provided a recommendation for an [...]

Go to Top